These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14685325)

  • 1. Exploring the active site of human factor Xa protein by NMR screening of small molecule probes.
    Fielding L; Fletcher D; Rutherford S; Kaur J; Mestres J
    Org Biomol Chem; 2003 Dec; 1(23):4235-41. PubMed ID: 14685325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening.
    Wang YS; Liu D; Wyss DF
    Magn Reson Chem; 2004 Jun; 42(6):485-9. PubMed ID: 15137040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit.
    Zbinden KG; Anselm L; Banner DW; Benz J; Blasco F; Décoret G; Himber J; Kuhn B; Panday N; Ricklin F; Risch P; Schlatter D; Stahl M; Thomi S; Unger R; Haap W
    Eur J Med Chem; 2009 Jul; 44(7):2787-95. PubMed ID: 19200624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation of a bound inhibitor of blood coagulant factor Xa.
    Studelska DR; McDowell LM; Adler M; O'Connor RD; Mehta AK; Guilford WJ; Dallas JL; Arnaiz D; Light DR; Schaefer J
    Biochemistry; 2003 Jul; 42(26):7942-9. PubMed ID: 12834346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (R)-3-Amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode.
    Mueller MM; Sperl S; Stürzebecher J; Bode W; Moroder L
    Biol Chem; 2002; 383(7-8):1185-91. PubMed ID: 12437104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand.
    Schärer K; Morgenthaler M; Paulini R; Obst-Sander U; Banner DW; Schlatter D; Benz J; Stihle M; Diederich F
    Angew Chem Int Ed Engl; 2005 Jul; 44(28):4400-4. PubMed ID: 15952226
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
    Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
    Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel search engine for virtual screening of very large databases.
    Vidal D; Thormann M; Pons M
    J Chem Inf Model; 2006; 46(2):836-43. PubMed ID: 16563015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening.
    Wyss DF; Arasappan A; Senior MM; Wang YS; Beyer BM; Njoroge FG; McCoy MA
    J Med Chem; 2004 May; 47(10):2486-98. PubMed ID: 15115392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and Xa.
    Smallheer JM; Alexander RS; Wang J; Wang S; Nakajima S; Rossi KA; Smallwood A; Barbera F; Burdick D; Luettgen JM; Knabb RM; Wexler RR; Jadhav PK
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5263-7. PubMed ID: 15454208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
    Jhoti H; Cleasby A; Verdonk M; Williams G
    Curr Opin Chem Biol; 2007 Oct; 11(5):485-93. PubMed ID: 17851109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
    Moore JM
    Biopolymers; 1999; 51(3):221-43. PubMed ID: 10516573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.
    Rios-Steiner JL; Murakami MT; Tulinsky A; Arni RK
    J Mol Biol; 2007 Aug; 371(3):774-86. PubMed ID: 17588602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.
    Rezaie AR
    Biochemistry; 2004 Mar; 43(12):3368-75. PubMed ID: 15035608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule fluorophores to detect cell-state switching in the context of high-throughput screening.
    Wagner BK; Carrinski HA; Ahn YH; Kim YK; Gilbert TJ; Fomina DA; Schreiber SL; Chang YT; Clemons PA
    J Am Chem Soc; 2008 Apr; 130(13):4208-9. PubMed ID: 18327938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes.
    Peltason L; Bajorath J
    Chem Biol; 2007 May; 14(5):489-97. PubMed ID: 17524980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human factor Xa bound amidine inhibitor conformation by double rotational-echo double resonance nuclear magnetic resonance and molecular dynamics simulations.
    McDowell LM; McCarrick MA; Studelska DR; O'Connor RD; Light DR; Guilford WJ; Arnaiz D; Adler M; Dallas JL; Poliks B; Schaefer J
    J Med Chem; 2003 Jan; 46(3):359-63. PubMed ID: 12540235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.